CD4 and infection: Nevertheless, the crecFib-4/11 vaccine was able to prevent a late drop of CD4+ T lymphocytes in the bursa of Fabricius, as observed in the challenge control, although a decrease in thymus was recorded in both challenged groups two weeks after infection, despite the absence of viral load in the organ at this time point.